Deventer Ziekenhuis — Clinical Trial Site

67 Registered trials

28 Currently recruiting

Organisation

Deventer Ziekenhuis

Location

Deventer, Netherlands

Identifier

ORG-100042576

Address

Nico Bolkesteinlaan 75, 7416 SE, Netherlands

Departments

#2910:Cardiology
#3705: Cardiology
2201:Kinderallergie Behandelcentrum
2603:Cardiology
3705: Cardiology
5001: Cardiology
Cardiology
Cardiology department
Clinical Pharmacy
Department of Oncology
Department of Pulmonology
Gynaecology
Hematology
ICU
Internal medicine
Interne Geneeskunde
Interne Oncologie
Kindergeneeskunde
Medica
Medical Oncology
Medical Oncology / Oncology center Deventer
N/A
Neurology
Obstetrics & Gynecology
Oncologie
Oncology
Ophthalmology
Pulmonology
Reproductive medicine and gynecology
Research oncology
Surgery
Vascular Surgery

Clinical trials at this site (67)

Search interface

THE EFFECT OF ABIRATERONE ON THE METABOLISM OF OXYCODONE (ENABLE study) Recruiting

2023-505705-17-00 Males aged  18 years with prostate cancer treated with 6 2024-02-23
Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-vol… Recruiting

2023-506698-36-00 low-volume metastatic castration-sensitive prostate can 5 2024-02-02
Anticoagulation for Stroke Prevention In patients with Recent Episodes of Atrial Fibrillation occurring transiently with stress Recruiting

2023-509142-35-00 Atrial fibrillation after stress (e.g., noncardiac surg 6 2024-01-29
A Phase 1, Dose-Escalating, Randomized, Placebo-Controlled, 4-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of COR-1… Recruiting

2023-508543-42-00 Chronic heart failure 1 2024-01-22
24 weeks double-blind randomized placebo-controlled trial to evaluate efficacy, PK, safety of LOU064 in adolescents (12 - <18) with CSU and … Recruiting

2022-502159-78-00 Chronic Spontaneous Urticaria 5 2023-12-06
Renal Lifecycle Trial: A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in … Recruiting

2023-508389-13-00 Combined endpoint of all-cause mortality, kidney failur 5 2022-11-08
The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: a randomized multi-center study in resectable HER2… Recruiting

2024-513797-22-00 HER2 positive esophageal adenocarcinoma 5 2022-03-09
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
DRUP trial Recruiting

2023-509152-33-00 Advanced solid tumor 4 2016-07-25
Prevention of the return of nephrotic syndrom in children by adding levamisole to prednisolone treatment Ended

2024-517467-23-00 steroid sensitive idiopathic nephrotic syndrome 5 2024-11-29
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
MAD Ended

2024-516379-34-00 Myopia 6 2024-08-02
DUTCH-WAIST Ended

2022-501392-81-00 Obesity 6 2024-07-25
TGF‐β And PDL‐1 inhibition with Bintrafusp alfa in Esophageal Squamous Cell carcinoma combined with chemoradiation TheRapY (TAPESTRY) Ended

2023-503312-32-00 Esophageal squamous cell carcinoma 4 2024-06-24
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation. Ended

2022-501939-16-00 Heart failure (HF) with mildly reduced ejection fractio 5 2023-05-09
Noisy Rebels; Non-inferiority study of rituximab compared to ocrelizumab in relapsing MS Ended

2022-502664-21-00 multiple sclerosis 6 2023-05-01
Does progesterone luteal phase support increase live birth rates in couples undergoing intra-uterine insemination with Mild Ovarian HyperSti… Ended

2022-501534-33-00 Unexplained Subfertility, infertility 6 2023-03-06
This study is to find out about the Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in… Ended

2023-505628-67-00 Relapsed and Refractory Follicular Lymphoma 5 2022-10-28
SEQUEL-Breast: a phase 2 study on the combination of alpelisib and fulvestrant after progression on previous therapy with fulvestrant in pat… Ended

2024-514965-20-00 Breast cancer 4 2022-06-02
A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
Induction chemotherapy for locally advanced rectal cancer. Ended

2023-509758-74-00 Locally advanced rectal cancer 4 2021-07-21